Tevogen Bio Holdings Inc. — Investor Relations & Filings

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company developing off-the-shelf, precision T cell therapies. The company utilizes its proprietary ExacTcell™ technology platform to harness the therapeutic potential of CD8+ cytotoxic T lymphocytes (CTLs), a key component of the natural immune system. This platform is designed to create treatments that specifically target antigens present only on diseased cells, thereby preserving healthy tissue and enhancing safety through the use of naturally occurring T cell receptors. The company's development pipeline addresses significant unmet medical needs across multiple therapeutic areas, including oncology, virology, and neurology, with a stated goal of providing affordable and accessible personalized therapies to large patient populations.